Collaboration in more than 46 countries.

You are leaving the country website to access another site in the group. Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.

NORTH AMERICA

Canada

United States

LATIN AMERICA

Argentina

Brazil

Mexico

Perú

GLOBAL

CEVA Global

EMEA (REGIONAL)

Denmark

Egypt

France

Germany

Hungary

Italy

Netherlands

Poland

Portugal

Romania

South Africa

Spain

Sweden

Tunisia

Turkey

Ukraine

United Kingdom

ASIA PACIFIC

Asia Pacific (Regional)

China

India

Indonesia

Japan

Korea

Malaysia

Philippines

Coxevac box and bottle
Coxevac box
Coxevac bottle
Coxevac box and bottle
Coxevac box
Coxevac bottle

Coxevac

Coxevac is an inactivated phase 1 vaccine designed to protect against Q Fever. As a result, vaccination can effectively reduce the clinical symptoms of the disease and minimize bacterial shedding.

Available in:

  • 40 ml

Target species:

  • cattle icon Cattle
  • Goat
  • sheep icon Sheep

Product information

How to use

• Suspension for subcutaneous injection, in the neck region
• Should be administered from 3 months of age
• Two doses should be given with an interval of 3 weeks as primary course and followed by a periodic booster

Goat drinking milk from a baby bottle

Why choose
Coxevac?

Empowers the Immunity

The only purified phase I C. burnetii vaccine that induces optimal cellular and humoral immune responses.

Tackles the reproductive impact

Effectively reduces the reproductive impact of Q Fever by decreasing abortion rates, increasing pregnancy rates, and reducing days open.

Less shedding

Lowers the probability of an animal becoming a shedder by 5 times and reduces the shedding of C. burnetii

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.